Home › Funds › Callodine Capital Management, LP › BTI

Callodine Capital Management, LP position in BTI

Brit Amern Tob Plc Sponsored C · Health Care

Callodine Capital Management, LP reported holding 1,958,107 shares of BTI (Brit Amern Tob Plc Sponsored C) in its Q3 2026 13F filing — a position valued at US$106.5M, representing 6.83% of its reported portfolio and ranking #3 among its reported holdings. Callodine Capital Management, LP has disclosed BTI holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)1.96M sh
Reported value held$106.52M
Portfolio Weight6.83%
First reportedQ2 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Callodine Capital Management, LP's BTI position evolved

Callodine Capital Management, LP first disclosed a stake in BTI in Q2 2025 at 527,500 shares (US$25.0M). The position peaked in Q3 2026 at 1,958,107 shares, worth US$106.5M. Across 6 filings, Callodine Capital Management, LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,958,107 shares valued at US$106.5M — an increase of 949,498 shares quarter over quarter.. Notable position changes include a 58% increase in Q1 2026 (shares rose 6% over the following quarter), a 94% increase in Q3 2026 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 527.50K $24.97M New
Q3 2025 607.80K $32.26M Add
Q4 2025 680.38K $38.52M Add
Q1 2026 1.08M $63.00M Add
Q2 2026 1.01M $62.29M Reduce
Q3 2026 1.96M $106.52M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BTI and 13F data

BTI (Brit Amern Tob Plc Sponsored C) is a Health Care company. 34 other funds we track also report a position in BTI — the largest reported positions include Capital International Investors (US$2.66B), Orbis Allan Gray Ltd (US$456.1M), Mondrian Investment Partners LTD (US$237.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BTI

All BTI fund holders →

FAQ

How long has Callodine Capital Management, LP held BTI?

Callodine Capital Management, LP has disclosed BTI holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Callodine Capital Management, LP's current position in BTI?

As of Q3 2026, Callodine Capital Management, LP holds 1.96M shares of BTI (Brit Amern Tob Plc Sponsored C), valued at $106.52M, representing 6.83% of its reported portfolio and ranking #3.

Has Callodine Capital Management, LP been buying or selling BTI?

In the latest 13F filing (Q3 2026), Callodine Capital Management, LP increased its position in BTI. The position peaked in Q3 2026 at 1.96M shares.

Which other funds hold BTI?

Other major institutional holders of BTI include Capital International Investors, Orbis Allan Gray Ltd, Mondrian Investment Partners LTD, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.